Data on drug overdose death rates, by drug type and selected population characteristics. Please refer to the PDF or Excel version of this table in the HUS 2019 Data Finder (https://www.cdc.gov/nchs/hus/contents2019.htm) for critical information about measures, definitions, and changes over time. SOURCE: NCHS, National Vital Statistics System, numerator data from annual public-use Mortality Files; denominator data from U.S. Census Bureau national population estimates; and Murphy SL, Xu JQ, Kochanek KD, Arias E, Tejada-Vera B. Deaths: Final data for 2018. National Vital Statistics Reports; vol 69 no 13. Hyattsville, MD: National Center for Health Statistics.2021. Available from: https://www.cdc.gov/nchs/products/nvsr.htm. For more information on the National Vital Statistics System, see the corresponding Appendix entry at https://www.cdc.gov/nchs/data/hus/hus19-appendix-508.pdf.

This data collection is part of the Monitoring the Future series that explores changes in important values, behaviors, and lifestyle orientations of contemporary American youth in eighth, tenth, and twelfth grades. The collection provides two datasets for each year since 1976 that are accessible only through the ICPSR Virtual Data Enclave VDE) and include original variables, including the unaltered weight variable, that in the public-use data were altered or omitted: one dataset without State, County, and Zip Code and one dataset including State, County, and Zip Code. Use of the geographic identifiers such as state, county, or zip code is limited and researchers interested in these variables are encouraged to read FAQs: About MTF Restricted-Use Geographic and Other Variables. Also included as part of each annual collection is a zip archive of the Monitoring the Future public-use data and documentation for each respective year. The basic research design used by the Monitoring the Future study involves annual data collections from eighth, tenth, and twelfth graders throughout the coterminous United States during the spring of each year. The 8th/10th grade surveys used four different questionnaire forms (and only two forms from 1991-1996) rather than the six used with seniors. Identical forms are used for both eighth and tenth grades, and for the most part, questionnaire content is drawn from the twelfth-grade questionnaires. Thus, key demographic variables and measures of drug use and related attitudes and beliefs are generally identical for all three grades. However, many fewer questions about lifestyles and values are included in the 8th/10th grade forms. Drugs covered by this survey include tobacco, smokeless tobacco, alcohol, marijuana, hashish, prescription medications, over-the-counter medications, inhalants, steroids, LSD, hallucinogens, amphetamines (stimulants), Ritalin (methylphenidate), Quaaludes (methaqualone), barbiturates (tranquilizers), cocaine, crack cocaine, ecstasy, methamphetamine, heroin, and GHB (gamma hydroxy butyrate). Other topics include attitudes toward religion, changing roles for women, educational aspirations, self-esteem, exposure to drug education, and violence and crime (both in and out of school).

This statistic describes the global pharmaceutical sales in from 2020 to 2024, sorted by regional submarkets. For 2024, total pharmaceutical sales in the United States was estimated to reach around *** billion U.S. dollars. World pharmaceutical sales by regionThe pharmaceutical industry is best known for manufacturing pharmaceutical drugs which aim to diagnose, cure, treat, or prevent diseases. The pharmaceutical sector represents a huge industry, with the global market being worth around *** trillion U.S. dollars. Among the best known top global pharmaceutical companies are Pfizer, Merck and Johnson & Johnson from the U.S., Novartis and Roche from Switzerland, Sanofi from France, etc. Accordingly, North America and Europe are still among the largest global submarkets for pharmaceuticals. In 2024, the United States was still the largest single pharmaceutical market, generating more than *** billion U.S. dollars of revenue. Europe was responsible for generating around *** billion U.S. dollars. These two markets, together with Japan, Canada and Australia, form the so-called established (or developed) markets. The rest of the global pharmaceutical revenue is mainly from emerging markets, which include countries like China, Russia, Brazil and India. In fact, these emerging markets show the fastest increase in pharmaceutical sales. Latin America is the world region with the highest predicted compound annual growth rate until 2028.